| SZ CAT No: | CL-DLS-02 |
| CAS No: | 115956-07-5 |
| Mol.F: | C10H15NO2 |
| Mol.Wt.: | 181.2 |
| Chemical Name: | (5s,6R,8r,9aS)-8-Hydroxyhexahydro-2H-2,6-methanoquinolizin-3(4H)-one |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Dolasetron USP Related Compound A is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Dolasetron USP Related Compound A is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(5s,6R,8r,9aS)-8-Hydroxyhexahydro-2H-2,6-methanoquinolizin-3(4H)-oneCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Dolasetron Molecular Formula: C10H15NO2
Molecular Weight: 181.2
Storage: Store in a cool, dry place.
Cat. No: CL-DLS-01
CAS No: 115956-12-2
Mol. F: C19H20N2O3
Mol. Wt: 324.4
Inv. Status: Custom Synthesis
Cat. No: CL-DLS-NO-01
CAS No: NA
Mol. F: C19H19N3O4
Mol. Wt: 353.4
Inv. Status: Custom Synthesis
Cat. No: CL-DLS-NO-02
CAS No: NA
Mol. F: C18H18N4O6
Mol. Wt: 386.4
Inv. Status: Custom Synthesis
Cat. No: CL-DLS-NO-03
CAS No: NA
Mol. F: C15H24N2O5
Mol. Wt: 312.4
Inv. Status: Custom Synthesis
Cat. No: CL-DLS-03
CAS No: NA
Mol. F: C18H20N2O4 : H2O
Mol. Wt: 328.4 : 18.0
Inv. Status: Custom Synthesis
Cat. No: CL-DLS-04
CAS No: 125483-30-9
Mol. F: C18H29NO6
Mol. Wt: 355.4
Inv. Status: Custom Synthesis
Cat. No: CL-DLS-05
CAS No: NA
Mol. F: C19H20N2O4
Mol. Wt: 340.4
Inv. Status: Custom Synthesis
Cat. No: CL-DLS-06
CAS No: 878143-33-0
Mol. F: C19H20N2O3 : CH4O3SH2O :
Mol. Wt: 324.4 : 96.1 : 18.0
Inv. Status: Custom Synthesis
| CAT No: | CL-DLS-02 |
| CAS No: | 115956-07-5 |
| Mol.F: | C10H15NO2 |
| Mol.Wt: | 181.2 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: